Skip to content
View UK Blog

Administering Stem Cells During Pregnancy to Infants with Neural Tube Defect Improves Quality of Life, Trial Finds

An innovative research effort has discovered that administering stem cells to developing infants suffering from spina bifida as part of a surgical repair may represent a "important advancement" in addressing congenital conditions.

Trial Details and Safety

The American study examined six fetuses with myelomeningocele. Doctors administered regenerative cells sourced from the maternal placenta to the surface of the developing neural column while the defect was being closed.

Significantly, the regenerative treatment was found to be safe. Researchers confirmed that the therapy did not induce cancerous growths, disrupt the healing process, or prevent the reversal of associated brain abnormalities.

Encouraging Results

Magnetic resonance imaging performed on the newborns indicated a successful correction of hindbrain herniation in every participant. This favorable anatomical change is strongly associated with improved motor skills and quality of life.

"If it makes a greater number of infants to achieve ambulation who wouldn't have, it may emerge as the conventional approach," said the lead researcher. "The results are profoundly encouraging and open the door to numerous possible new treatments."

Long-Term Prospects and Optimism

Commentators reviewing the findings have suggested that additional validation of these noted improvements could herald a "different age" in prenatal intervention. The prospect of enhancing neural deficits seen in utero is considered a paradigm-shifting aim.

Particularly welcome would be advancements for bladder and bowel function, which are common challenges for people affected by this defect.

Future Directions

While this initial trial involved a limited number of patients, its confirmed tolerability and hopeful trends create a solid basis for broader investigative efforts. The combination of regenerative medicine with current in-utero repair procedures offers substantial hope for changing life trajectories for future generations with myelomeningocele.

About the author

Monica Smith

A London-based journalist passionate about uncovering stories that shape modern British society and culture.

View UK Blog

Type to search articles.